(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
2 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 6.86%
Live Chart Being Loaded With Signals
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States...
Stats | |
---|---|
Today's Volume | 16 419.00 |
Average Volume | 72 954.00 |
Market Cap | 19.33M |
EPS | $0 ( 2024-03-26 ) |
Next earnings date | ( $-0.820 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.160 |
ATR14 | $0.00700 (0.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-23 | Ledru Philippe | Buy | 0 | |
2024-02-05 | Payne Fletcher | Buy | 55 000 | Employee Stock Option (Right to Buy) |
2024-02-05 | Bejar Rafael | Buy | 35 000 | Employee Stock Option (Right to Buy) |
2024-02-05 | Ledru Philippe | Buy | 11 000 | Employee Stock Option (Right to Buy) |
2024-02-05 | Rice William G. | Buy | 70 000 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 93 transactions |
Buy: 9 955 760 | Sell: 545 471 |
Aptose Biosciences Inc Correlation
10 Most Positive Correlations | |
---|---|
CFRX | 0.958 |
FWRD | 0.955 |
RMRM | 0.954 |
AGRX | 0.954 |
PACB | 0.953 |
AKAN | 0.951 |
BGFV | 0.947 |
QNRX | 0.947 |
EMBC | 0.945 |
PETS | 0.944 |
10 Most Negative Correlations | |
---|---|
TBSA | -0.973 |
AGGR | -0.972 |
AEAC | -0.971 |
AVAC | -0.969 |
SCOB | -0.969 |
KAII | -0.969 |
CRZN | -0.968 |
JUGG | -0.968 |
LEGA | -0.968 |
MSAC | -0.967 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aptose Biosciences Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-474 545 (0.00 %) |
EPS: | $-7.72 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-474 545 (0.00 %) |
EPS: | $-7.72 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-507 079 (0.00 %) |
EPS: | $-6.67 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.730 |
Financial Reports:
No articles found.
Aptose Biosciences Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS; and APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. It has agreements with CrystalGenomics, Inc. and OHM Oncology. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators